Phase I Study of the Safety and Preliminary Efficacy of Intracerebral Transplantation of HuCNS-SC Cells for Connatal Pelizaeus-Merzbacher Disease (PMD)
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Adult neural stem cells (Primary)
- Indications Pelizaeus-Merzbacher disease
- Focus Adverse reactions
- Sponsors StemCells
- 02 Aug 2013 Two-year data was presented at the 2013 Pelizaeus-Merzbacher Disease Symposium and Health Fair, according to a StemCells media release.
- 21 Mar 2013 New trial record